Sonoma Pharmaceuticals Inc (SNOA)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SNOA market cap is 3.22M. The company's latest EPS is USD -2.9924 and P/E is -0.67.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.14M | 3.44M | 3.39M | 3.58M | 3.56M |
| Operating Income | -844k | -1.41M | -1.17M | -850k | -1.03M |
| Net Income | -866k | -1.07M | -1.14M | -610k | -928k |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.94M | 18.63M | 12.63M | 13.27M | 12.74M |
| Operating Income | -6.67M | -3.45M | -5.89M | -4.57M | -4.7M |
| Net Income | -2.95M | -3.95M | -5.09M | -5.15M | -4.84M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.62M | 14.74M | 13.67M | 13.69M | 13.67M |
| Total Liabilities | 7.93M | 8.6M | 8.7M | 8.33M | 8.8M |
| Total Equity | 6.69M | 6.14M | 4.98M | 5.35M | 4.87M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.56M | 14.99M | 18.85M | 16.23M | 14.74M |
| Total Liabilities | 5.86M | 9.62M | 10.15M | 8.25M | 8.6M |
| Total Equity | 8.71M | 5.36M | 8.7M | 7.98M | 6.14M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.55M | -2.4M | -912k | -558k | 7k |
| Investing | -20k | -2k | -5k | -31k | -33k |
| Financing | 1.05M | 1.68M | 636k | 2.08M | 2.79M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.54M | -3.38M | -4.25M | -6.15M | -2.4M |
| Investing | 3.59M | 388k | -99k | -258k | -2k |
| Financing | 1.03M | 3.31M | 7.4M | 2.49M | 1.68M |
| Market Cap | 3.22M |
| Price to Earnings Ratio | -0.67 |
| Price to Sales Ratio | 0.25 |
| Price to Cash Ratio | 1.03 |
| Price to Book Ratio | 0.52 |
| Dividend Yield | - |
| Shares Outstanding | 1.62M |
| Average Volume (1 week) | 18.31k |
| Average Volume (1 Month) | 22.29k |
| 52 Week Change | -34.11% |
| 52 Week High | 9.374 |
| 52 Week Low | 1.99 |
| Spread (Intraday) | 0.06 (2.9%) |
| Company Name | Sonoma Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.sonomapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
